Informationen:
Fehler:
ID
21865
Beschreibung
Tailored Treatment in Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00396487
Link
https://clinicaltrials.gov/show/NCT00396487
Stichworte
Versionen (1)
- 04.05.17 04.05.17 -
Hochgeladen am
4. Mai 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Metastatic Colorectal Cancer NCT00396487
Eligibility Metastatic Colorectal Cancer NCT00396487
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Metastatic Colorectal Cancer NCT00396487
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Colorectal cancer metastatic
Item
metastatic colorectal cancer
boolean
C0948380 (UMLS CUI [1])
Primary tumor Verification Histopathologic
Item
histopathological verification of the primary tumor
boolean
C0677930 (UMLS CUI [1,1])
C1711411 (UMLS CUI [1,2])
C0677043 (UMLS CUI [1,3])
C1711411 (UMLS CUI [1,2])
C0677043 (UMLS CUI [1,3])
Measurable Disease
Item
measurable disease according to resist criteria
boolean
C1513041 (UMLS CUI [1])
Indication Single agent chemotherapy
Item
single agent chemotherapy indicated
boolean
C3146298 (UMLS CUI [1,1])
C3846440 (UMLS CUI [1,2])
C3846440 (UMLS CUI [1,2])
performance status
Item
performance status >=2
boolean
C1518965 (UMLS CUI [1])
Age
Item
age >= 60 years
boolean
C0001779 (UMLS CUI [1])
Life Expectancy
Item
life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
Liver function | Renal function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver | Creatinine measurement, serum
Item
adequate liver and kidney function as evaluated by bilirubin <= 3 times of normal upper limit, alat <= 3 times upper normal limit (<= 5 times upper normal limit in case of liver metastases), serum creatinine <= 1.5 times normal upper limit.
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0494165 (UMLS CUI [5])
C0201976 (UMLS CUI [6])
C0232804 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0494165 (UMLS CUI [5])
C0201976 (UMLS CUI [6])
Absolute neutrophil count | Platelet Count measurement
Item
anc >=1.5 x 109/l and platelets >= 100 x 109/l
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0032181 (UMLS CUI [2])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
CNS metastases
Item
patients with cns metastases
boolean
C0686377 (UMLS CUI [1])
Malignant Neoplasms | Skin carcinoma | Carcinoma in situ of uterine cervix
Item
other malignant disease within the last 5 years except for non-melanoma skin cancer and carcinoma in situ of cervix uteri
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
C0699893 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
Chemotherapy Neoplasm Metastasis
Item
previous chemotherapy for metastatic disease
boolean
C0392920 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,2])
Chemotherapy, Adjuvant
Item
adjuvant chemotherapy < 6 months before inclusion
boolean
C0085533 (UMLS CUI [1])
Toxic reaction Major Investigational New Drugs | Allergic Reaction Major Investigational New Drugs
Item
patients with previous major toxic or allergic reaction to the protocol drugs
boolean
C0542243 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C1527304 (UMLS CUI [2,1])
C0205164 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
C0205164 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C1527304 (UMLS CUI [2,1])
C0205164 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])